Triphasil

Background: This study was conducted to probe the existence of oral contraceptive (OC)-induced psychological side effects that… Expand

Objective: To assess patient compliance with a transdermal contraceptive and to compare rates of perfect compliance with a… Expand

Gender‐based differences in cytochrome P450 (CYP) activity may occur due to endogenous hormonal fluctuations with the menstrual… Expand

Objective: The apoptosis pathway is a vital mechanism in vivo that functions to eradicate genetically damaged cells prone to… Expand

The objectives of the study were to follow-up six artificial menstrual cycles induced by Triphasil® in order to determine: 1) the… Expand

This study assessed serum lipid, lipoprotein and apolipoprotein changes during one year in 3 groups of nonsmoking women: 1… Expand

Levonorgestrel, as used in oral contraceptives, has antiovulatory activity at doses far lower than those producing androgenic… Expand

Three hundred thirteen women participated in an open, multicenter comparison of the incidence of intermenstrual bleeding… Expand

Triphasil, a low-dose combination oral contraceptive containing levonorgestrel and ethinyl estradiol, was tested in four Planned… Expand

The new ultra-low-dose triphasic oral contraceptive (OC) Triphasil represents a 63% reduction in progestogen compared with the… Expand